Antithrombin supplementation during extracorporeal membrane oxygenation: study protocol for a pilot randomized clinical trial

BACKGROUND: Normal levels of plasma antithrombin (AT) activity might decrease heparin requirements to achieve an adequate level of anticoagulation during treatment with extracorporeal membrane oxygenation (ECMO). Acquired AT deficiency during ECMO is common, but formal recommendations on target, tim...

Descripción completa

Detalles Bibliográficos
Autores principales: Panigada, Mauro, Spinelli, Elena, Cucino, Alberto, Cipriani, Elisa, De Falco, Stefano, Panarello, Giovanna, Occhipinti, Giovanna, Arcadipane, Antonio, Sales, Gabriele, Fanelli, Vito, Brazzi, Luca, Novembrino, Cristina, Consonni, Dario, Pesenti, Antonio, Grasselli, Giacomo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558738/
https://www.ncbi.nlm.nih.gov/pubmed/31186035
http://dx.doi.org/10.1186/s13063-019-3386-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558738/
https://www.ncbi.nlm.nih.gov/pubmed/31186035
http://dx.doi.org/10.1186/s13063-019-3386-4

Ejemplares similares